Jasper Hellweg
Stock Analyst at Argus Research
(4.12)
# 1,633
Out of 4,707 analysts
242
Total ratings
56.8%
Success rate
7.5%
Average return
Main Sectors:
Stocks Rated by Jasper Hellweg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VTRS Viatris | Maintained: Buy | $20 | $16.61 | +20.41% | 5 | Sep 8, 2026 | |
| ILMN Illumina | Maintained: Buy | $100 → $235 | $211.06 | +11.34% | 13 | Sep 2, 2026 | |
| MRNA Moderna | Upgraded: Buy | $180 | $140.33 | +28.27% | 15 | Aug 27, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | $145 → $170 | $148.46 | +14.51% | 7 | Aug 24, 2026 | |
| AMGN Amgen | Rated: Buy | $360 → $460 | $393.17 | +17.00% | 7 | Aug 18, 2026 | |
| NVO Novo Nordisk | Maintained: Hold | n/a | $45.16 | - | 8 | Aug 7, 2026 | |
| BMY Bristol-Myers Squibb Company | Upgraded: Buy | $75 | $64.69 | +15.94% | 5 | Aug 4, 2026 | |
| NVS Novartis AG | Maintained: Buy | $160 → $170 | $137.70 | +23.46% | 3 | Jul 24, 2026 | |
| BIIB Biogen | Maintained: Hold | n/a | $212.50 | - | 6 | Jul 10, 2026 | |
| SWX: ALC Alcon Inc. | Maintained: Buy | CHF 68.71 | CHF 55.82 | +23.09% | 5 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $23.97 | - | 7 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $48.54 | - | 2 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $73.56 | - | 12 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $220 → $250 | $248.78 | +0.49% | 5 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $55 | $54.07 | +1.72% | 3 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $345 → $560 | $497.97 | +12.46% | 11 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $810.31 | n/a | 13 | Jun 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $120 | $146.64 | n/a | 7 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 | $24.86 | n/a | 3 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $36.76 | n/a | 9 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1,123.91 | n/a | 4 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 → $60 | $43.16 | n/a | 3 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $465 → $550 | $528.90 | n/a | 11 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $105 → $125 | $126.20 | n/a | 8 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 → $70 | $124.40 | n/a | 6 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $26 | $4.85 | n/a | 5 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $285 → $225 | $171.62 | n/a | 6 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $324.86 | n/a | 3 | Sep 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $135 → $165 | $235.50 | n/a | 6 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $475 → $500 | $401.94 | n/a | 5 | Feb 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $260 → $290 | $259.21 | n/a | 5 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $195 → $275 | $402.02 | n/a | 6 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $43 → $50 | $44.98 | n/a | 3 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $6.00 | n/a | 5 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 → $135 | $108.20 | n/a | 5 | May 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $135 → $115 | $50.86 | n/a | 4 | Jun 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $14.58 | n/a | 3 | Apr 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $288.83 | n/a | 4 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $57.21 | n/a | 1 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 | $20.14 | n/a | 2 | Aug 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $213.25 | n/a | 1 | Aug 31, 2016 |
Viatris
Sep 8, 2026
Maintained: Buy
Price Target: $20
Current: $16.61
Upside: +20.41%
Illumina
Sep 2, 2026
Maintained: Buy
Price Target: $100 → $235
Current: $211.06
Upside: +11.34%
Moderna
Aug 27, 2026
Upgraded: Buy
Price Target: $180
Current: $140.33
Upside: +28.27%
Merck & Co.
Aug 24, 2026
Reiterated: Buy
Price Target: $145 → $170
Current: $148.46
Upside: +14.51%
Amgen
Aug 18, 2026
Rated: Buy
Price Target: $360 → $460
Current: $393.17
Upside: +17.00%
Novo Nordisk
Aug 7, 2026
Maintained: Hold
Price Target: n/a
Current: $45.16
Upside: -
Bristol-Myers Squibb Company
Aug 4, 2026
Upgraded: Buy
Price Target: $75
Current: $64.69
Upside: +15.94%
Novartis AG
Jul 24, 2026
Maintained: Buy
Price Target: $160 → $170
Current: $137.70
Upside: +23.46%
Biogen
Jul 10, 2026
Maintained: Hold
Price Target: n/a
Current: $212.50
Upside: -
Alcon Inc.
Jul 1, 2026
Maintained: Buy
Price Target: CHF 68.71
Current: CHF 55.82
Upside: +23.09%
Jun 23, 2026
Maintained: Buy
Price Target: n/a
Current: $23.97
Upside: -
Jun 8, 2026
Maintained: Buy
Price Target: n/a
Current: $48.54
Upside: -
May 26, 2026
Downgraded: Hold
Price Target: n/a
Current: $73.56
Upside: -
May 13, 2026
Reiterated: Buy
Price Target: $220 → $250
Current: $248.78
Upside: +0.49%
Apr 6, 2026
Upgraded: Buy
Price Target: $55
Current: $54.07
Upside: +1.72%
Mar 3, 2026
Rated: Buy
Price Target: $345 → $560
Current: $497.97
Upside: +12.46%
Jun 30, 2025
Downgraded: Hold
Price Target: n/a
Current: $810.31
Upside: n/a
May 5, 2025
Reiterated: Buy
Price Target: $100 → $120
Current: $146.64
Upside: n/a
Feb 24, 2025
Upgraded: Buy
Price Target: $40
Current: $24.86
Upside: n/a
Jan 30, 2025
Maintained: Buy
Price Target: $20
Current: $36.76
Upside: n/a
Jan 22, 2025
Maintained: Buy
Price Target: n/a
Current: $1,123.91
Upside: n/a
Jul 26, 2024
Maintained: Buy
Price Target: $55 → $60
Current: $43.16
Upside: n/a
Jun 17, 2024
Maintained: Buy
Price Target: $465 → $550
Current: $528.90
Upside: n/a
Apr 29, 2024
Maintained: Buy
Price Target: $105 → $125
Current: $126.20
Upside: n/a
Apr 25, 2024
Maintained: Buy
Price Target: $90 → $70
Current: $124.40
Upside: n/a
Dec 7, 2022
Upgraded: Buy
Price Target: $26
Current: $4.85
Upside: n/a
Oct 24, 2022
Maintained: Buy
Price Target: $285 → $225
Current: $171.62
Upside: n/a
Sep 19, 2022
Downgraded: Hold
Price Target: n/a
Current: $324.86
Upside: n/a
Aug 17, 2022
Maintained: Buy
Price Target: $135 → $165
Current: $235.50
Upside: n/a
Feb 7, 2022
Maintained: Buy
Price Target: $475 → $500
Current: $401.94
Upside: n/a
Sep 10, 2021
Maintained: Buy
Price Target: $260 → $290
Current: $259.21
Upside: n/a
Aug 2, 2021
Maintained: Buy
Price Target: $195 → $275
Current: $402.02
Upside: n/a
Jun 7, 2021
Maintained: Buy
Price Target: $43 → $50
Current: $44.98
Upside: n/a
May 5, 2021
Downgraded: Hold
Price Target: n/a
Current: $6.00
Upside: n/a
May 3, 2021
Maintained: Buy
Price Target: $95 → $135
Current: $108.20
Upside: n/a
Jun 12, 2020
Maintained: Buy
Price Target: $135 → $115
Current: $50.86
Upside: n/a
Apr 17, 2020
Downgraded: Hold
Price Target: n/a
Current: $14.58
Upside: n/a
Mar 24, 2020
Downgraded: Hold
Price Target: n/a
Current: $288.83
Upside: n/a
Oct 30, 2019
Downgraded: Hold
Price Target: n/a
Current: $57.21
Upside: n/a
Aug 15, 2019
Upgraded: Buy
Price Target: $40
Current: $20.14
Upside: n/a
Aug 31, 2016
Downgraded: Hold
Price Target: n/a
Current: $213.25
Upside: n/a